Paul G Higgins Selected Research

Paul G Higgins Research Topics

Disease

17	Infections 02/2024 - 05/2004
2	COVID-19 04/2024 - 07/2023
2	Urinary Tract Infections (Urinary Tract Infection) 01/2022 - 07/2019
1	Clinical Deterioration 04/2024
1	Post-Acute COVID-19 Syndrome 04/2024
1	Mpox (monkeypox) 02/2023
1	Bacteremia 01/2022
1	Sepsis (Septicemia) 01/2022
1	Pneumonia (Pneumonitis) 11/2021
1	Gonorrhea 11/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2021
1	Dysbiosis 08/2021
1	Cross Infection (Nosocomial Infection) 01/2021
1	Ventilator-Associated Pneumonia 03/2020
1	Critical Illness (Critically Ill) 10/2019
1	Clostridium Infections 01/2019
1	Bites and Stings (Sting) 01/2013
1	Meningococcal Infections 02/2004

Drug/Important Bio-Agent (IBA)

6	Colistin (Coly-Mycin)FDA Link 11/2022 - 01/2019
5	Carbapenems (Carbapenem Antibiotics)IBA 02/2024 - 11/2017
4	Anti-Bacterial Agents (Antibiotics)IBA 11/2022 - 10/2019
3	Edetic Acid (EDTA)FDA Link 07/2023 - 11/2021
2	WastewaterIBA 07/2023 - 02/2023
2	carbapenemaseIBA 07/2023 - 01/2021
2	nitroxolineIBA 01/2022 - 07/2019
2	Sulbactam FDA LinkGeneric 01/2022 - 05/2004
1	Niclosamide FDA Link 04/2024
1	Interleukin-1beta (Interleukin 1 beta)IBA 04/2024
1	Fluvoxamine (Luvox)FDA LinkGeneric 04/2024
1	Interleukin-8 (Interleukin 8)IBA 04/2024
1	CytokinesIBA 04/2024
1	Antiviral Agents (Antivirals)IBA 04/2024
1	Interleukin-6 (Interleukin 6)IBA 04/2024
1	Bromhexine (Bisolvon)IBA 04/2024
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2024
1	Cyproheptadine (Periactin)FDA Link 04/2024
1	Oxygen (Dioxygen)IBA 04/2024
1	ceftazidime drug combination avibactamIBA 07/2023
1	Aztreonam FDA LinkGeneric 07/2023
1	Viral DNAIBA 02/2023
1	Tigecycline (Tygacil)FDA Link 12/2021
1	Azithromycin (Zithromax)FDA LinkGeneric 11/2021
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 11/2021
1	SteroidsIBA 08/2021
1	Amdinocillin (Mecillinam)FDA Link 07/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Imipenem FDA Link 01/2019
1	Amino Acids FDA Link 02/2015
1	bacterial fibronectin-binding proteinsIBA 02/2015
1	cyclic diadenosine phosphateIBA 01/2013
1	RNA (Ribonucleic Acid)IBA 01/2013
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	Bacterial DNAIBA 01/2013
1	Bacterial RNAIBA 01/2013
1	Tazobactam FDA LinkGeneric 05/2004
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 05/2004
1	Virulence Factors (Pathogenicity Factors)IBA 02/2004
1	OligosaccharidesIBA 02/2004

Therapy/Procedure

7	Therapeutics 11/2022 - 01/2019
1	Investigational Therapies (Experimental Therapy) 01/2022
1	Patient Admission (Patient Admissions) 01/2022
1	Catheters 11/2021
1	Vascular Access Devices (Arterial Line) 11/2021
1	Fecal Microbiota Transplantation 08/2021
1	Cell Transplantation 08/2021
1	Transplantation 01/2019